Charged phospholipid compositions and methods for their use

Details for Australian Patent Application No. 2001278336 (hide)

Owner Ottawa Heart Institute Research Corporation Liponex, Inc.

Inventors Sparks, Daniel L.

Agent FB Rice

Pub. Number AU-B-2001278336

PCT Pub. Number WO02/09678

Priority 60/221,916 31.07.00 US

Filing date 31 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 18 January 2007

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 31/663 (2006.01)

A61K 31/683 (2006.01) - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

A61K 31/685 (2006.01)

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 39/02 (2006.01) General protective or antinoxious agents

Event Publications

10 April 2003 Amendment Made

  The nature of the amendment is: Amend the invention title to read Charged phospholipid compositions and methods for their use

19 January 2006 Amendment Made

  The nature of the amendment is: Add the co-applicant Daniel L. Sparks

18 January 2007 Assignment before Grant

  Ottawa Heart Institute Research Corporation; Sparks, Daniel L. The application has been assigned to Ottawa Heart Institute Research Corporation; Liponex, Inc. 2002

18 January 2007 Application Accepted

  Published as AU-B-2001278336

8 February 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Jan 2007. Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000

29 March 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Jan 2007. Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000

10 May 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 13 Apr 2007. Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000

31 May 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Jan 2007

7 June 2007 Change of Name(s) of Applicant(s), Section 104

  Liponex, Inc.; Ottawa Heart Institute Research Corporation The name of the applicant has been changed to Ottawa Heart Institute Research Corporation

19 July 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Mar 2007 2002

2 August 2007 Standard Patent Sealed

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001278337

2001278335